Clinical Perinatal Software Market Share

Clinical Perinatal Software Market Share Analysis

Product Segmentation: The clinical perinatal software market is divided into two types of products: integrated software and standalone software. Integrated software, offering better effectiveness and advantages, holds the majority share, accounting for 75.8% in 2016. The global market for clinical perinatal software is anticipated to grow from USD 166.43 million in 2016 to USD 294.60 million by 2023, showing a growth rate of 7.2% from 2017 to 2023.

Services Breakdown: In terms of services, the market is categorized into implementation services, maintenance services, consulting services, customization services, community engagement, and online resources. Among these, implementation services had the highest share in 2016, representing the most widely used service. The implementation services market is expected to reach USD 73.31 million by 2023, growing at a rate of 7.5% from 2017 to 2023.

Deployment Models: For deployment models, the options are on-premises and cloud-based/VPNS. In 2016, on-premises deployment held the largest share, making up 73.3% of the global market. The overall clinical perinatal software market, based on deployment models, is predicted to grow at a rate of 7.2% from 2017 to 2023.

Applications Spectrum: In terms of applications, the market encompasses fetal monitoring, data entry, patient record, and others. Fetal monitoring data services secured the largest market share at 57.0% in 2016, driven by increasing birth rates and pre & post-date pregnancies.

Regional Analysis: The global clinical perinatal software market is analyzed regionally, with segments including the Americas, Europe, Asia Pacific, and the Middle East & Africa. In 2016, the Americas held the largest market share at 39.2%, attributed to high healthcare spending and growing awareness. Europe followed as the second-largest market, and Asia Pacific emerged as the fastest-growing region, offering significant growth opportunities. In contrast, the Middle East & Africa had the smallest market share in 2016.

Forecast for the Americas: Specifically, the Americas clinical perinatal software market was valued at USD 65.31 million in 2016 and is projected to reach USD 112.93 million by 2023, exhibiting a CAGR of 6.9% during the forecast period.

In essence, the clinical perinatal software market presents a diverse landscape with different product types, services, deployment models, applications, and regional variations. The anticipated growth underscores the increasing importance of these technologies in monitoring maternal health and fetal well-being.